Randox to deliver £10m investment for major UK research project

Home - Business News

Randox to deliver £10m investment for major UK research project

About Randox       News        Contact Us

Diagnostics and personalised health company Randox to deliver £10m investment for major UK research project Our Future Health

Randox, the Northern Ireland-based diagnostics and personalised health company, has today been announced as one of four new industry partners in the Our Future Health (OFH) programme, which will be the UK’s largest ever health research programme.

Randox will deliver a £10m investment in the programme, which will discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.

The company is one of four new partners who will deliver a total of £40m to OFH. They join 10 additional life sciences companies that were previously announced as funding partners in January 2022. As well as its £10m investment, Randox will contribute its world-leading expertise to the programme. Its network of 20 High Street clinics, including those in Holywood and Crumlin, will also be available if required to test volunteers from across the UK taking part in the OFH project. The project aims to monitor the long-term health of 5 million volunteers in the coming years, starting this autumn.

Andrew Roddam, Chief Executive of OFH, said: “We are delighted to be announcing a further four industry partners for OFH, who together will provide an additional £40m to further our objective to develop new ways to prevent, detect and treatments enabling people to live healthier lives for longer.  We welcome Randox as one of these partners, knowing their long-term commitment to diagnostics, and look forward to working with them in the months and years ahead.”

OFH has also joined with 16 health research charities, who have endorsed the pilot phase of the programme and are providing valuable support and experience.

Volunteers will be asked to complete an online health questionnaire, give their informed consent to link information from their healthcare records to OFH and donate a small blood sample.

Volunteers are also being asked to give their permission for OFH to contact them in the future to give them the opportunity to take part in follow-on research and to provide personal feedback about their health, should they wish to receive it.

Researchers from across the life sciences community, including academia, industry and the NHS, will be able to apply to study OFH resources as part of their crucial research to accelerate the discovery and development of innovative diagnostics and treatments.

Volunteers’ data will be de-identified and held in ‘trusted research environments’ that meet strict security criteria and an access board, which will include independent experts and members of the public, to ensure OFH resources are only used for health research in the public interest.

Randox Managing Director, Dr Peter FitzGerald said:

“Randox has been engaged from the very outset and is now excited to formally support this world-leading research project, both as a funding member and with our considerable expertise.

“With over 40 years of diagnostic experience, and extensive research capabilities, Randox knows that a personalised approach to the early detection and prevention of disease is not only critical to saving and extending life, but also to improving the quality of our lives. This project will further those critical goals. The ability for participants to receive feedback on their health from the project, and to engage with future research, also promotes Randox’s objective of greater individual ownership of health.

“Randox is committed to providing accessible and affordable testing to drive significant health improvements through the early detection and prevention of disease. ‘Our Future Health’ is perfectly aligned with that vision.”

Members of the public who are interested in taking part in Our Future Health later this year can register for news and updates  at www.ourfuturehealth.org.uk

 

For more information contact:
Mia Taylor
mia.taylor@woburnpartners.com
+44 (0) 7891525749
James Robinson
james.robinson@woburnpartners.com

Want to know more?

Contact us

Related Pages

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


EUROMEDLAB 2022

We are attending EUROMEDLAB 2022!

 

 

Come visit us in Munich from 10th-14th April at EuroMedlab 2022!

We will be at stand 7  where you can discover how we are currently revolutionising healthcare with our innovative products!

 

Our Extensive Product Range

With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at Hall 3, Stand 218 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 3 day event.

Meet The Team

Our Product Specialists Team will be available to answer any questions, but why not plan ahead? Request a meeting by clicking on the team member’s photo to secure a dedicated time slot to talk with a Randox representative.

 

null

Dipesh Varu

Regional Sales Manager, Midlands and East Anglia

Dipesh has worked for Randox Laboratories for the last 7 years. Very experienced when it comes to our Acusera range of products.

 

 

 

 

 

null

Ben Crawford

Molecular Product Specialist,  Team Leader

Ben has been working at Randox for 5 years and during his time he has become an expert in the field of molecular diagnostics. Stop by our booth and discuss Qnostics, QCMD, Vivalytic, Discovery and more with Ben.

null

Jana Kohutova

Sales Manager Slovakia

After study of General Biology at University of Matej Bel (Slovakia) Jana started working at RANDOX in the Sales Department Slovakia in July 2005. Continual business development with best possible effectiveness and profitability for company is my long-term key focus in RANDOX Slovakia. Sales projects contribute of all RANDOX product range including biochip array technology, molecular arrays.

 

 

 

 

null

Remy Patton

Business Development Manager, Poland

Remy is the Business Development Manager for Poland and the Balkans (Croatia, Serbia, Macedonia, Bosnia), actively promoting the clinical product portfolio. Graduating from Edinburgh Napier University with a Biomedical Science degree and have been working in Randox sales department since September 2019.

 

 

 

null

Bryony Boyd

European Sales Manager

Bryony Boyd is one of the Randox European Sales Managers for the clinical product portfolio. A biomedical science graduate from University of Ulster, Bryony has been actively promoting the Randox clinical portfolio to the Baltics, Austria, Slovenia, Greece, Cyprus and Switzerland. Her main focus is IQC, EQA, Rx Series, Vivalytic and Reagents.

 

 

 

 

null

Heidi Dowswell

Product Specialist, European Region

Heidi is the Randox Product Specialist for the European region. A Zoology graduate from Queen’s University Belfast, Heidi has actively been promoting the Randox clinical portfolio to the Nordics, BeNeLux, Albania, Moldova and Romania. Her main focus is IQC, EQA, Rx Series, Reagents and Vivalytic. Heidi has been working in Randox since 2019, firstly as a Technical Support Scientist and now as a Product Specialist in the sales department.

 

 

 

null

Esin Yildiz

Business Development Manager

Esin is a Business Development Manager For Balkan Countries, Germany, France, Turkey and Portugal. Esin focuses on Food and Tox.

 

 

 

null

Diana Adashankar

Business Development Manager, France

After a Master’s degree in BioEngineering and BioTechnologies in the Healthcare Industry, Diana has gained experience as Marketing and Sales Executive for more than 7 years in the medical & pharmaceutical field.

 

 

 

 

null

Alexander Genin

National Sales Manager , France

Alexander followed an International Business Administration bachelor and specialised in innovation management Master degree at the Rotterdam School of Management in the Netherlands. He moved into his first role within Randox as Sales Representative. After 2 successful years, he moved to a Sales Team Leader position and then to the National Sales Manager position. He is 100% dedicated to improving healthcare in France and in accompanying Randox in doing so worldwide.

 

 

 

null

Luciano Colucci

International Sales Manager, South East Italy

Luciano has been working in Randox since March 2010 as sales consultant for south-east Italy. Dedicated to develop and follow customer for centre-south Italy. As Sales Manager, he is focused on QA, Reagents, Toxicology and molecular product. Luciano also has a private interest to organic farming dedicated to improving human nutrition.

 

 

null

Alessandro Vallone

International Sales Manager, Italy

Alessandro is an International Sales Manager with years of experience in drug testing monitoring and creating tailor-made solutions for laboratories, hospitals and government facilities.

 

 

 

 

null

Rachel Foresyth

Molecular Product Specialist

Rachel Forsythe began her career with Randox working as a Biochip Analyst and Extraction Scientist in the COVID Laboratories during the pandemic. Rachel is now working as a Molecular Product Specialist on a global scale. She also specialises in the Randox Point of Care analyser, the VeraSTAT for both clinical and veterinary as she studied Zoology in University.

null

Ray Cameron

Head of Service Engineering

Ray has been in Randox since 2013 and has extensive experience from roles in sales support, technical training and management of the global service group.

 

 

 

null

James Crilly

Marketing Manager

Since joining the company in 2015, James has been part of the Quality Control Marketing team, promoting our range of Acusera controls, RIQAS EQA programmes and Acusera 247 data management software across the globe. He also has experience in the promotion and marketing of Qnostics and QCMD. More recently he has moved to a corporate role and now part of the team responsible for managing our advertising, events, marketing automations, sponsorships and more.

 

 

null

Martin Conway

Marketing Manager 

Martin is one of the clinical marketing team managers, promoting our diverse range of analysers including Chemistry, Immunoassay, Molecular and Point of Care. He also has experience in collaborative promotion and corporations with our business partners and distribution network along with experience in advertising, events, sponsorships and more.


Global Leaders combine to provide pre-race COVID testing of UAE Team Emirates

About Randox       News        Contact Us

Monday 28th March 2022: Global Leaders combine to provide pre-race COVID testing of UAE Team Emirates

Randox, a world leader in Health Diagnostics has been announced as the Official Supplier of UAE Team Emirates. The two-time winners of cycling’s most prestigious prize, the Tour de France.

The agreement will see UAE Team Emirates utilise the Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch Healthcare Solutions to test riders and the wider support staff for COVID prior to upcoming races and tours.

The Bosch Vivalytic brings innovation to the Molecular Diagnostic testing market. A fully automated, sample to point of care diagnostic machine with the full molecular workflow consolidated into one small benchtop platform.

The ethos of improving healthcare which drove Randox Managing Director Dr Peter Fitzgerald to start the company in the 1980s is clearly reciprocated by their new partners. From their initiation into the top tier of professional cycling in 2017, UAE Team Emirates have had the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle through cycling.

Team UAE Emirates are the newest addition to Randox’s growing portfolio of elite sporting sponsorships, which includes; GB Olympic and Paralympic teams, Sheffield United Football Club, Olimpia Milano and the Aintree Randox Grand National. The first endeavour into the United Arab Emirates sporting industry comes as no surprise as Randox have been providing UAE Hospitals, Universities and Veterinary centres with their broad range of products and services, offering a comprehensive insight into patient diagnosis to facilitate more effective disease management and treatment for a number of years.

Giulio Saule, Randox International Sales Manager stated:

“For a Global Company such as Randox it is an honour to be supplier of COVID tests to UAE Team Emirates, a team that in both 2020 and 2021 won the Tour de France and ended in the top 5 of the UCI Teams Ranking. The effort of the team in talents looks exactly the same as Randox effort in bringing innovative technologies on the market. This cooperation then brings Randox in one of the elite sports where surely there may be different horizons than COVID.”

 

Andrea Agostini, chief operating officer UAE Team Emirates stated:

We have paid a lot of attention against this virus since the beginning. For us the health of our members is a priority and to have the possibility to test them always, autonomously, during the cycling season is a big advantage.

About Team UAE

UAE Team Emirates entered the highest level of professional cycling, the World Tour, in early 2017. The team has the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle linked to the use of the bicycle.

Season after season, the Emirati team has attracted a growing number of world-class riders and quality sponsors, taking them to new heights and successes in the biggest races in the world. The culmination of this growth and success has come with the victories of Tadej Pogacar in the Tour de France in 2020 and 2021.

 

For further information please contact James Crilly;  james.crilly@randox.com / 028 9442 2413

 

Want to know more?

Contact us or visit UAE Team Emirates.

Related Pages

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


IBMS Congress 2022

We are attending IBMS Congress!

Come visit us at The National Convention Centre (ICC) from 14th-17th March 2022.

We will be in Hall 3, Stand 218 where you can discover how we are currently revolutionising healthcare with our innovative products!

Our Extensive Product Range

With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at Hall 3, Stand 218 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 3 day event.

Meet The Team

Click on the team member’s photo to request a meeting

null

Barry Maguire

Clinical Sales Manager, South England

Barry joined Randox 5 years ago and he currently leads our team in the South of England. Barry also manages some customer accounts directly in North England and has a keen interest in our IQC software package, Acusera 24.7.

 

null

Dipesh Varu

Regional Sales Manager, Midlands and East Anglia

Dipesh has worked for Randox Laboratories for the last 7 years. Very experienced when it comes to our Acusera range of products.

 

null

Ben Crawford

Molecular Product Specialist,  Team Leader

Ben has been working at Randox for 5 years and during his time he has become an expert in the field of molecular diagnostics. Stop by our booth and discuss Qnostics, QCMD, Vivalytic, Discovery and more with Ben.

null

Veena Vara

Sales Executive, North West England

Veena started working for Randox within the clinical team 4 years ago after completing BSc and MSc in Biomedical Science.

 

null

Jenna Ireland

Sales Executive, South-West England

Jenna completed her University Placement with Randox whilst working within the Global sales team. She has currently been working for Randox for 3.5 years

null

Tome Cardoso

Sales Executive, London

Tome is a Sales Executive using his extensive experience in the lab to help our customers find the best solutions for their testing needs by using innovative Randox products. Tome has experience as a Biomedical Scientist at a Senior level having worked in several hospitals across London for the past 7 years.

 

null

Conor Gallagher

Sales Manager, Ireland

Conor has been working for Randox for over 7 years and managing the Irish market for the majority of that time. Conor has taken a keen interest in a new range of POC EQA products that Randox has launched. Please feel free to call by the stand to discuss these products in more detail

 

null

Dermot Devlin

Business Development Executive, Scotland & Wales

Dermot has spent 2 years travelling extensively in Sub Saharan Africa and Asia promoting the importance of quality within the laboratory, Dermot is now focusing his time on developing the Randox ethos in both Scotland and Wales.

 

null

Chuckwuma Georgewill Manjor

Sales Executive, Ireland

Chukwuma has been with Randox for over a year now and specialises in clinical sales within our Irish sales team in particular to Point of Care, Research and University institutions.

null

Adam Wilson

Molecular Product Specialist, Ireland

Adam is the newest addition to the Irish Team. Adam’s  focus within the team is the molecular product range. If you have any queries regarding any of the molecular products please feel free to call by and he will be happy to discuss these with you.

null

Ashleigh Rudd

Sales Executive, South Central England

Ashleigh recently started working for Randox having previously been a Biomedical Scientist in Microbiology, Haematology and Blood Transfusion.


Response to release of specified minutes, notes and correspondence relating to Government contracts awarded to Randox

Randox Logo

   

4th February 2022: Response to release of specified minutes, notes and correspondence relating to Government contracts awarded to Randox

A spokesperson for Randox said:

“It is clear from these papers that Randox contracts were awarded in full compliance with government procedures and protocols in place at a time of the emerging pandemic.

“The awarding of the contracts reflected Randox’s extensive diagnostics capabilities within the UK and 40 years of experience in that field. As Secretary of State, Sajid Javid says in his statement, the service Randox provided was integral to the rapid building, from scratch, of the largest ever testing industry in UK history.

“Randox’s laboratories expanded rapidly in order to operate at scale and were the first laboratory to report over 100,000 PCR results in a day. It is clear from these papers that the company has delivered a vital and core part of the UK’s testing capacity.

“Randox remains proud of its performance and delivery of Covid 19 testing throughout the pandemic. To date Randox has reported almost 24 million PCR results and has played a key role in both keeping people safe and sustaining vital national infrastructure.

“Unlike other laboratories Randox was able from the outset to provide whole-system capabilities to deliver the tests. Both the World Health Organisation and the UK government agreed this capability was crucial to combating the pandemic.”

For all media enquiries, please contact Ian Monk on ian@ianmonk.com or  +44 7970 026072 / + 44 203 011 1933

Randox in the media

Latest News

FAQs


2 years on…since the development of the Randox COVID-19 Biochip

COVID-19 Testing        News        Contact Us

Wednesday 02 February 2022: 2 years since the Randox COVID-19 Biochip

February 2022 marks 2 years since the development of the Randox COVID-19 Biochip.

In February 2020, based on almost four decades of experience in diagnostic R&D, including the development of a CE marked panel of tests for fifteen respiratory viruses, as well as tests for SARS and MERS, Randox recognised the threat from COVID-19 and quickly developed a test to accurately identify the virus.

And a lot has happened since then…

Randox’s capability was recognised by the UK government and since March 2020 Randox has been contracted to provide COVID-19 testing support to the UK’s Pillar 2 National Testing Programme. The company immediately pivoted to move from a 9-5 business to a 24|7 operation.

Through the enormous effort and commitment of its staff Randox has (at the time of writing) processed more than 23 million gold-standard PCR tests for the National Testing Programme and for international travel – providing a reliable service to enable COVID-safe travel which facilitates personal, family and business engagements and activities during the pandemic.

Demonstrating its commitment to helping people live their lives as easily and normally as possible, and to enhance accessibility to travel testing, the company partnered with major airlines including British Airways, Easyjet, Ryanair, Wizz Air, Cathay Pacific, and Jet2, travel providers such as TUI, and travel agents including the DNATA Travel Group, to provide discounted travel tests. By investing in testing capacity, logistic capabilities, and the introduction of a dedicated Customer Support team, Randox could make greater efficiencies that allowed it to reduce the price of PCR testing and become the most competitive service in the UK and Ireland.

During the 2020 Olympic Games, Randox got Team GB safely to the starting line in Tokyo by providing the Olympians with its premium COVID-19 testing, a service which it also provided for the ParalympicsGB athletes. A number of other sporting organisations opted to make Randox their COVID-19 testing provider of choice for their players and supporting staff, including the Irish Football Association, the US Men’s National Soccer Team, and Premiership Rugby, to ensure a COVID-safe training environment. Using Randox diagnostic technologies, companies like Norbrook Laboratories and Northern Ireland Screen were able to implement a staff screening programme that demonstrated a high standard of duty of care to their employees.

As and when required, Randox rapidly established new customer-focused services catered to the needs of the ever-changing travel testing guidelines. In May 2021, for example, Randox launched a ‘test to return’ service for UK holidaymakers returning home from Portugal and requiring predeparture tests before their return flight. In a first for the industry, passengers were able to take their PCR kit to Portugal and return their sample to one of Randox’s partner labs in the Algarve, before Randox flew the samples back to its labs in the UK for testing.

2 years on

The company also provides tests for COVID-19 antibodies, as well as lateral flow testing services, where such tests satisfy international travel requirements, and has developed an innovative phone app to securely process and verify customer identification and results in just 15 minutes.

Randox has amongst the very largest laboratories in Europe and since the start of the pandemic has built, equipped and staffed 80,000 sq ft of PCR testing facilities, in Northern Ireland, Manchester and Greater London, and 50,000 sq ft of supporting logistic and engineering space. Randox has opened a number of mobile testing labs as well as almost 30 travel clinics, for COVID-19 testing appointments and over-the-counter home testing kit purchases. Walk-through and drive-through test centres have opened across a number of key airport locations, some in partnership with renowned travel services provider Collinson.

Randox is the only testing provider in the UK within this reporting period to have reported over 100,000 PCR results in a single day. Turnaround times for test results are rigorously monitored to meet the needs of both Government and private customers.

The company has more than doubled its workforce since 2020 and has developed a robust and comprehensive nationwide logistics network for the timely distribution and return of sample collection kits and samples.  In collaboration with reputable partners including Morrisons supermarkets, Wells Pharmacies, Roadchef and PayPoint, Randox has established almost 200 PCR sample dropboxes and over 1500 click and collect sites, with the aim of improving customer accessibility and simplifying the process of COVID-19 testing requirements.

By responding rapidly, dynamically and cost-effectively to an ever-changing environment, with updates to travel testing requirements often being made at short notice, Randox has played an important role in managing the effects of the pandemic in both the UK and Ireland, facilitating safe social and economic activity, including international travel.

 

For further information on Covid testing services please contact the Randox Covid Customer Support team on 028 9434 3005.

For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com

 

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TEST TO RELEASE

LABORATORY TOOLS


Randox provides Team GB’s COVID testing for Beijing Winter Olympic Games

COVID-19 Testing        News        Contact Us

Tuesday 01 February 2022

Gold standard testing for Great Britain’s Olympians: Randox provides Team GB’s COVID-19 testing for Beijing Winter Olympic Games

As part of the two-year partnership between Randox and The British Olympic Association,  the Team GB Olympians competing in the Olympic Winter Games 2022 have used Randox COVID-19 tests to ensure they touch down in Beijing free of COVID and have the best possibility opportunity to compete without the fear of being ruled out on health grounds.

The ‘stop the virus’ logistics drive mirrors a similar and highly successful regime which ensured that Team GB landed in Japan for the 2020 Olympic Games COVID-free, and that no athlete was forced to withdraw in Tokyo because of infection or close contact with someone who had tested positive.

Despite fears that the virus could impact Team GB’s Olympic hopes, the rigorous testing programme put in place helped UK sporting stars to rack up 54 medals – their best-ever performance at an overseas Games bar the 67 medals won in Rio in 2016.

To provide its gold-standard PCR testing services, Randox created a bespoke dashboard for Team GB to register its samples, which will be taken by the Team GB Clinical Team and then transported to the company’s laboratories which are located in Manchester, Greater London and Northern Ireland.

Randox is testing a delegation of 200 Olympians, coaches and support staff in order to meet China’s testing requirements and thereby minimising possible transmission of the virus in Beijing. Randox is providing each member of Team GB with four rounds of pre-departure tests and can offer rapid same-day testing on the day of flying as an extra precaution.

At the time of the announcement of the partnership between Randox and the British Olympic Association, in June 2021, Randox Managing Director, Dr Peter FitzGerald, said:

“We are delighted to be supporting Team GB by helping them get safely to the starting line in Tokyo with our premium Covid-19 testing services, the provision of which has been a major focus of ours since the outbreak of the pandemic. Over the last year, we have been investing significantly in our customer service and testing capacity, which means Randox can now process over 500,000 tests per day, making it the largest laboratory in Europe, and to date has processed over 13 (now 23) million tests. For this reason, our Olympians and anyone else who needs to travel internationally can rest assured that they will receive timely results.”

British Olympic Association CEO, Andy Anson, said:

“This is a fantastic and vital partnership for Team GB ahead of Tokyo 2020 and Beijing 2022. We have committed to our hosts in Japan and the IOC to ensure that our delegation is fully vaccinated and are also ensuring we have enhanced Covid testing in place. Randox’s pedigree in this area gives us great confidence that we are providing athletes with the best possible medical support around Covid testing and that they get to the start line safely ready to compete successfully for the biggest moment of their sporting careers.”

Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to allow international travellers to travel with confidence.

Beijing Winter Olympic Games 2022

Pictured with a Randox COVID-19 Predeparture Test is English freestyle skier Katie Summerhayes

For further information on Covid testing services please contact the Randox Covid Customer Support team on 028 9434 3005.

For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com 

 

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TEST TO RELEASE

LABORATORY TOOLS


Randox sponsors Science Summer School Northern Ireland

About Randox       News        Contact Us

Monday 31st January 2022: Randox sponsors Science Summer School Northern Ireland

An official launch for Science Summer School Northern Ireland 2022 has taken place at the Ryobi headquarters in Carrickfergus.

Ryobi are the headline sponsor of the Science Summer School Northern Ireland event, which aims to inspire young people to become the next generation of scientists with an inspirational programme that mixes the best of STEAM (Science, Technology, Engineering, Arts and Maths) through a series of seminars, discussions and hands-on experiments.

On Friday, the Deputy Mayor of Mid and East Antrim, Lord Andrew Mawson OBE, Richard Mallett, and representatives from the other main sponsors, Terumo Blood and Cell Technologies, Randox, Almac, NRC and IPC Mouldings all gathered in Carrickfergus to officially launch the event which will take place later this year.

The Science Summer School initiative was established in 2012 at St. Paul’s Way Trust School in East London by Lord Andrew Mawson OBE and Professor Brian Cox CBE. The project is now expanding nationally with the aim to make ‘the UK the best place to do science and engineering in the world’.

Deputy Mayor, Councillor Matthew Armstrong, said:

 “Council’s Manufacturing Task Force are delighted to be working with a range of local businesses, schools, universities and partner organisations to bring this exciting opportunity to the borough.

“We are thrilled that this event is now going accessible to young people in Mid and East Antrim.

“Our hope is that they will be inspired to embark on a future in science and maybe even become leaders in that field.”

Managing Director of Ryobi, Marco Emig, said: 

 “Ryobi are delighted to be the headline sponsor of this event.

“Science and the desire to learn more about how our world works, and about how we can use that information to improve how we live our lives, has never been more attractive or relevant as a subject area and a potential career path.

“We are very much looking forward to seeing the creative ideas generated from our young people.”

Lord Mawson OBE said: 

 “The Science Summer School initiative here in Northern Ireland will activate the curiosities of the young people who take part and hopefully inspire them to great things.

“This annual celebratory event and the allied programme of STEAM related activity throughout the year provides a vital catalyst to bring together different partners from education and enterprise.  I am delighted to see so many companies have ‘signed up’ to support our first event this year.

 “There is never a better time to be bringing the Science School Northern Ireland hosted by Professor Cox to Ballymena.”

For further information please contact randoxpr@randox.com

Want to know more?

Contact us using the details below.

Related Pages

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


National STIQ Day 2022

COVID-19 Testing        News        Contact Us

National STIQ Day 2022

14th January, National STIQ day was launched to get people thinking about the importance of sexual health and encourage everyone to get regular health checks.

More than 30 different bacteria, viruses and parasites are known to be transmitted through sexual contact. Eight of these pathogens are linked to the greatest incidence of sexually transmitted diseases (STI’s). STI’s are spread predominantly by sexual contact, including vaginal, anal and oral sex. Some STI’s can also be transmitted from mother-to-child during pregnancy, childbirth, and breastfeeding.

Any individual can catch an STI regardless of what age they are, their sexuality or how many sexual partners they have, as it only takes one sexual encounter to increase the risk of catching an infection. The importance of regular STI testing allows individuals to get peace of mind and take control of their sexual health as many infections don’t present symptoms and it’s advised that testing is required if individuals are concerned about their health, present symptoms or change sexual partner. Regular screening can aid in detecting an infection in the early stages and help to reduce the risk of such complications.

The increase in STI’s underline the need for urgent action which many reports have highlighted the need of ongoing inaction and development of strategies to improve sexual health. It has been widely noted by the CDC that over 20 million new STI’s are detected each year. (1) Public Health England also reported that 468,342 diagnoses of STIs had been reported in England in 2019 – a 5% increase from 2018 with a 26% increase in gonorrhoea infections, 10% increase in syphilis and 7% increase in the number of consultations at national sexual health services. It’s also widely noted that chlamydia testing, which is most common in young adults has declined by 13% since 2015 and 2% of all individuals tested had received a positive diagnosis. (2) (3)

Here at Randox, we offer solutions for clinical laboratories, point of care testing solutions and home STI testing kits for convenience and discretion. Randox provides the broadest STI testing menu on the market. Detecting 10 bacterial, viral, and protozoan infections, the STI test provides a comprehensive sexual health profile. The CE-marked STI Array provides the identification of co-infections, often in asymptomatic individuals and enable antibiotic stewardship.

The Randox test presents excellent precision, specificity, sensitivity and accuracy for STI diagnoses, which reduces the risk of false reporting and unnecessary confirmatory tests. The Randox simultaneous multiplex test means smaller sample volumes are required, enabling faster throughput and rapid patient diagnosis saving time and money for clinical and laboratories.

The Randox STI Multiplex test detects the following infections:

  • Chlamydia trachomatis (CT)
  • Neisseria gonorrhoeae (NG)
  • Trichomonas vaginalis (TV)
  • Mycoplasma genitalium (MG)
  • Treponema pallidum (Syphilis) (TP)
  • Herpes simplex virus 1 (HSV-1)
  • Herpes simplex virus 2 (HSV-2)
  • Haemophilus ducreyi (HD)
  • Mycoplasma hominis (MH)
  • Ureaplasma urealyticum (UU)

 

Does your laboratory or clinic carry out STI testing? Our molecular analyser, the Bosch Vivalytic and Evidence Investigator, powered by patented Biochip Array Technology, could be the diagnostic solution you need!

Solutions for the Laboratory

54 SAMPLES ● 1 TEST ● 10 INFECTIONS

 The Evidence Investigator is a compact semi-automated benchtop analyser ideal for medium throughput laboratories.

  • Sample Type: Swab or Urine
  • Sample Volume: 300 μl
  • Detection Method: Randox Biochip Technology (end-point PCR)
  • Time to Result: 5 hours 30 minutes

 

STI Testing at the Point of Care

1 SAMPLE ● 1 TEST ● 10 INFECTIONS

The Bosch Vivalytic enables sample to answer, cartridge based molecular diagnostics at

the point of care. Powered by Randox Biochip Technology.

  • Sample Type: Swab or Urine
  • Sample Volume: 300 μl
  • Detection Method: Randox Biochip Technology (end-point PCR)
  • Time to Result: 2 hours 30 minutes

 

For more information about our STI Arrays or Vivalytic email: marketing@randox.com

  1. https://www.cdc.gov/std/life-stages-populations/adolescents-youngadults.htm
  2. https://www.tht.org.uk/news/rise-stis-underlines-need-urgent-action
  3. Sexually transmitted infections (STIs) (who.int)

Related Products and Services

Evidence Investigator

Biosciences

ANTIBODY TEST

Vivalytic


Randox and PayPoint partner to boost accessibility of Day 2 lateral flow tests

COVID-19 Testing        News        Contact Us

The updated collaboration opens up PayPoint’s extensive retail network to offer increased convenience to travellers returning to the UK

Randox and PayPoint have today announced an expansion of their partnership, to boost access to COVID-19 testing and provide a vital service to travellers returning to the UK, in line with the Government’s new arrival requirements for Day 2 testing, announced on Wednesday 5th January.

The expanded partnership between PayPoint and Randox will mean even easier access to low-cost COVID-19 testing, by enabling people to order a Randox test online for click and collect at a local store within the Collect+ network, initially available in over 5,000 locations, and soon in over 10,000 locations nationwide.

The service launches on 7th January 2022 to coincide with changes to travel policy which, from 4am on 9th January, allows fully vaccinated arrivals from non-red list countries to take a lateral flow (antigen) test, with a PCR test only required if a positive lateral flow result is returned.

In addition, from mid-January, PayPoint will give consumers the ability to walk into a local store and pick up a test immediately in over 2,500 locations, with no need to order online. This service will be offered in partnership with major convenience retailers including Scotmid Co-operative and Spar in the North West and Scotland.

Dr Peter FitzGerald, Managing Director at Randox said: “By drawing on our 40 years’ diagnostics experience, unparalleled testing capacity, and well-established logistics network, which now includes an extensive number of new locations from PayPoint, Randox is able to respond quickly to changing travel requirements and simplify the process of ordering Day 2 lateral flow tests.

“The availability of value for money tests that can be collected at the customer’s convenience thanks to our partnership with PayPoint means people in the UK don’t need to wait for home delivery or a walk-in clinic appointment when ordering a COVID-19 test.”

Nick Wiles, Chief Executive at PayPoint said: “Our expanded partnership with Randox will deliver yet another vital service to help keep people safe in communities across the UK.  Consumer convenience and accessibility are at the very heart of what we do and this is another example of our agility, responsiveness and the great relationships we have with our retailer partners in the ever-changing landscape across the UK.”

Day 2 lateral flow tests must be ordered before travel to England and can be ordered from 4am on 7th January. Thanks to the updated collaboration between PayPoint and Randox, people can now conveniently collect these tests from local stores for just £18.95, rather than waiting at home for deliveries to arrive.

Using the free Randox CertiFly App results are processed within 3 hours and a report delivered in-app and via email, allowing arrivals into England to complete their Day 2 test conveniently in the comfort of their own home, and for individuals who test positive, potentially reducing the amount of time they need to isolate.

Visit covid.randox.com to purchase COVID-19 tests from Randox Health.

Related COVID-19 Products and Services

CERTIFLY LATERAL FLOW

HOME TEST - PCR

ANTIBODY TEST

LABORATORY TOOLS


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)